Microbiota analysis could help sexual assault investigations by detecting microbial markers of contact, even in cases where traditional DNA evidence is lacking.
Celine Druart, from the Pharmabiotic Research Institute, discusses the new European regulation concerning substances of human origin and the impact on microbiome research and therapeutic development.
Preclinical findings will be presented at the American Association for Cancer Research (AACR) Annual Meeting in Chicago.
L-ornithine can be an additional therapy to boost the efficacy of ustekinumab in people with Crohn’s disease.
By addressing biases and increasing diversity in microbiota studies, researchers can develop more accurate and inclusive health strategies for women of different backgrounds.
This pioneering three-in-one formula uniquely combines pasteurized Akkermansia muciniphila AKK PROBIO, DigeSEB® broad-spectrum digestive enzymes, and B-Complex vitamins.
Matthew Cheng, CEO of Kanvas Biosciences, introduces the company’s cutting-edge spatial biology platform, developed to provide deeper insights into host-microbiome interactions.
Reproducible biomarkers produced by several bacteria show potential as a non-invasive tool for IBD diagnosis, discriminating ulcerative colitis and Crohn’s disease patients from healthy individuals.
Treatment with the probiotic Lactobacillus murinus improved social behavior and partially restored gut and brain function.
Maitrayee Chatterjee, Ph.D., Project Manager and Senior Scientist at InnoGI Technologies, discusses their innovative and non-invasive platform to mimic both the upper and lower gastrointestinal tract, offering precise and standardized…
